Life Sciences

Whether your team of researchers and innovators is developing a new drug or medical device, seeking FDA approval, devising an exit strategy, going public or staying private, Weaver’s diverse team of experts possesses deep knowledge of the intellectual property landscape, regulatory requirements, reimbursement strategies, and commercial aspects. With a profound depth and breadth of experience in the life sciences industry, our professionals can guide you carefully and confidently through any phase of your development process.

Connect with us

Assisting you to go public.

Weaver offers integrated services that help you with compliance standards for developing new drugs and devices, going public and establishing IPOs, selling your company, and investor relations. Our team knows how to plan your exit strategy and how to structure your taxes — no matter what you decide.

Once you’re public, our professionals can help you with comprehensive tax, audit advisory services for public companies. Our experience gives us the ability to ask the right questions and to help you with some of the most important transitions you’ll face.

Helping you to stay public.

Our professionals know the tax structures and exit strategies for staying private, too. Weaver’s team offers valuations, equity instruments, audit preparation and a host of services covering regulatory standards and business process improvements for the life sciences industry. We’ll help you stabilize and be prepared for new opportunities as they come.

Featured